High-Spatial-Resolution Lower Extremity MR Angiography at 3.0 T: Contrast Agent Dose Comparison Study
- 1 August 2008
- journal article
- research article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 248 (2), 680-692
- https://doi.org/10.1148/radiol.2482071505
Abstract
To determine whether contrast material dose reduction at 3.0 T allows preserved image quality for high-spatial-resolution magnetic resonance (MR) angiography of the lower extremities.Forty-five consecutive patients (27 men, 18 women; mean age, 64 years) underwent contrast material-enhanced MR angiography of the lower extremities at 3.0 T. A waiver of informed consent was granted by the institutional review board. Sixteen patients received high-dose (approximately 0.3 mmol/kg), 15 received intermediate-dose (approximately 0.2 mmol/kg), and 14 received low-dose (approximately 0.1 mmol/kg) gadopentetate dimeglumine during a three-station, dual-injection examination. For scoring purposes, the arterial system from the celiac trunk to the plantar arteries was divided into 34 segments. The images were retrospectively and independently evaluated by two specialized radiologists who were blinded to the patient dose groups. All studies were assessed for overall image quality and the degree of contaminating venous enhancement. Each arterial segment was scored for the quality of vessel definition, the severity of stenoses, and the presence of collateral vessels.More than 99% of arterial segments were found to be of diagnostic image quality by both readers in all dose groups. Generalized estimating equation analysis showed a significant difference among the three groups with regard to vessel definition (P = .019). No significant difference was found between the high- and intermediate-dose groups; however, the low-dose group had significantly better vessel definition compared with the high-dose (P = .034) and intermediate-dose (P = .015) groups. There was no significant difference among the groups in visualization of collateral vessels. Venous contamination was seen less frequently in the low-dose group, but the difference did not achieve significance.The study showed that, compared with widely used dose strategies at 1.5 T, the contrast agent dose for 3.0-T lower extremity MR angiography can be reduced multifold without compromising image quality.Keywords
This publication has 36 references indexed in Scilit:
- Nephrogenic Systemic Fibrosis: Risk Factors and Incidence EstimationRadiology, 2007
- Magnetic Resonance Angiography of Abdominal and Lower Extremity VasculatureTopics in Magnetic Resonance Imaging, 2005
- Bolus-chasing contrast-enhanced 3D MRA of the lower extremity. Comparison with intraarterial DSA.Acta Radiologica, 2003
- Gadolinium as an alternative contrast agent for diagnostic and interventional angiographic procedures in patients with impaired renal functionNephrology Dialysis Transplantation, 2002
- Peripheral Magnetic Resonance AngiographyTopics in Magnetic Resonance Imaging, 2001
- Renal Tolerance of a Neutral Gadolinium Chelate (gadobutrol) in Patients with Chronic Renal Failure: Results of a Randomized StudyRadiology, 2001
- Safety of intravenous gadolinium (Gd-BOPTA) infusion in patients with renal insufficiencyAmerican Journal of Kidney Diseases, 2000
- Aortoiliac and Lower Extremity Arteries: Comparison of Three-dimensional Dynamic Contrast-enhanced Subtraction MR Angiography and Conventional AngiographyRadiology, 1999
- Nephrotoxicity of high‐dose gadolinium compared with iodinated contrastJournal of Magnetic Resonance Imaging, 1996
- Arteriographic complications in the DSA era.Radiology, 1992